SocGen Uses Lyxor To Push OTCs In Asia
Amid dwindling demand for over-the-counter equity derivatives, Société Générale is touting its Lyxor Asset Management managed account products platform to institutional investors in Hong Kong to lure them towards more sophisticated hedging strategies.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts